16 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
of advanced analytics and AI continues to accelerate, the TRUST team partnered with our Cyber Digital Trust team to issue guidance on the use of large
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
of cyber threats in each business were provided in order to strengthen cybersecurity awareness and address emerging threats. The Company conducted a crisis
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:11am
of cyber threats in each business were provided in order to strengthen cybersecurity awareness and address emerging threats. The Company conducted
6-K
0ymq25o8h 7ksj
27 May 20
Current report (foreign)
6:05am
424B3
ck00zwpg4z dz6rh1q
14 Nov 19
Prospectus supplement
6:10am
F-4/A
v82x51aearvh26h1qnp
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
srfumtf9rf 5kav
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
ljqndoc bw
27 Jun 19
Annual report (foreign)
6:41am
6-K
unzmtfy oamp2za
30 May 19
Current report (foreign)
10:26am
20FR12B/A
9p8kivg54yn2c6
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
89ynrert920ye2
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
n962kj
16 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next